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Objective. To investigate the association between paternal smoking and childhood acute lymphoblastic leukemia (ALL). Method.
We identiﬁed 18 published epidemiologic studies that reported data on both paternal smoking and childhood ALL risk. We
performed a meta-analysis and analyzed dose-response relationships on ALL risk for smoking during preconception, during
pregnancy, after birth, and ever smoking. Results. The summary odds ratio (OR) of childhood ALL associated with paternal
smoking was 1.11 (95% Conﬁdence Interval (CI): 1.05–1.18, I2 = 18%) during any time period, 1.25 (95% CI: 1.08–1.46,
I2 = 53%) preconception; 1.24 (95% CI: 1.07–1.43, I2 = 54%) during pregnancy, and 1.24 (95% CI: 0.96–1.60, I2 = 64%) after
birth, with a dose-response relationship between childhood ALL and paternal smoking preconception or after birth. Conclusion.
The evidence supports a positive associationbetween childhood ALL and paternal ever smoking and at each exposure time period
examined.Futureepidemiologicstudiesshouldassesspaternalsmokingduringwell-deﬁned exposurewindowsandshouldinclude
biomarkers to assess smokingexposure and toxicological mechanisms.
1.Introduction
Leukemia is the most common cancer in children and ado-
lescents, accounting for about 1 out of 3 cancers in children
[1]. Each year, around 3,250 children are diagnosed with
leukemia, of which about 2,400 are acute lymphoblastic leu-
kemia (ALL) cases [2]. In the USA, survival rate for children
with ALL has improved markedly since the early 1970s and
is now approximately 80%, but incidence rates have not
decreased and have, in fact, increased by 0.8% annually
from 1975 to 2007 [3]. Worldwide, according to the World
Health Organization (WHO), there were 33,142 deaths
from leukemia among children under age 15 in 2004, and
childhood (<15 years) leukemia caused 1,228,075 disability
adjusted life years (DALYs) [4]. Identifying risk factors for
childhood leukemia is an important step in the reduction of
the overall burden of childhood diseases.
Though it has been studied intensively, the etiology of
childhood leukemia is not well established. A two-hit model
was proposed by Greaves in which prenatal chromosome
alterations and postnatal genetic alterations are necessary for
childhood leukemia development [5]. Genetic susceptibility
and environmental factors play potential roles in this process
[6]. Ionizing radiation has been signiﬁcantly linked to
childhood leukemia [7]; evidence for an association with
benzene exposure or with parental smoking and alcohol
consumption is less convincing.
Multiplestudieson parental smoking and childhood leu-
kemiahavebeenconductedinthepasttwodecades,probably
because tobacco smoke is a well-documented and prevalent
carcinogen. Despite ongoing global eﬀorts to reduce tobacco
use,onebillionmenand250millionwomencurrentlysmoke
worldwide [8], causing 5 million deaths and 57 million
D A L Y sf r o mc a n c e ra n do t h e rd i s e a s e se a c hy e a r[ 9]. In the
USA, 46 million people or 24% of all adults smoke [10],
which caused nearly half a million deaths and 5 million
years of potential life lost each year from 2000 to 2004 [11].
In China, though smoking is uncommon among women,
almost two thirds of men smoke [12], causing one million
deaths each year to smokers [13] and 56,000 deaths and
480,000 DALYs from lung cancer and ischemic heart disease
to nonsmokers [14].2 Journal of Oncology
At least 250 chemicals in tobacco smoke are known to
be toxicorcarcinogenic, includingvolatileorganic chemicals
like benzene, formaldehyde, aromatic amines, polycyclic
aromatic hydrocarbons (PAHs), and nitrosamines and ra-
dioactive compounds like Polonium-210 [15]. Benzene has
been shown to aﬀect the blood-forming system at low levels
[16], and formaldehyde hasbeenshown to increase leukemia
risk among exposed adults [17]. Smoking is causatively
linked with adult leukemia [18], and secondhand smoke
(SHS) is qualitatively similar in its chemical constituents to
mainstream smoke [15], indicating that SHS exposure has
the potential to cause adverse eﬀect on the hematopoietic
system. Children aged 6 to 11 years were reported to have
urinary concentrations of the tobacco-speciﬁc carcinogen
nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-
ol (NNAL) nearly four times those of adult nonsmokers
[19], indicating that children are less able to avoid exposure
to SHS than adults. Smoking has also been shown to
aﬀect sperm morphology, motility, and concentration and
to increase oxidative damage to sperm DNA [20]. Together,
these ﬁndings indicate that parental smoking is a potential
risk factor for childhood leukemia that could induce DNA
damage and mutation pre- and postnatally. However, epi-
demiological studies on this topic have reported inconsistent
ﬁndings. Through 2009, 20 studies [21–40]i n v e s t i g a t e d
maternal smoking and childhood ALL, with three studies
[27, 36, 39] reporting statistically positive associations, two
[32, 40] reporting statistically negative associations, and the
remainder reporting nonsigniﬁcant association. Among the
18 studies on paternal smoking, eight showed increased risks
of childhood ALL for at least one index (exposure level or
time period) of paternal smoking [23, 27, 33, 34, 36, 37, 41,
42].
Given the extent of the exposure, the known carcino-
genicity of tobacco smoke, and the inconsistent ﬁndings for
paternal smoking and childhood leukemia risk, a thorough
examination of the causal association between paternal
smoking and childhood ALL, a major type of leukemia in
children, is necessary. A recent meta-analysis by Lee et
al. [42] found a signiﬁcantly positive but weak associ-
ation between paternal smoking preconception (but not
after birth) and risk of childhood leukemia and ALL [42].
This analysis was based on 11 studies published from
1990 to 2008, plus their own study, results of which were
published concurrently with the meta-analysis. However,
Lee’s meta-analysis did not include all published studies and
did not suﬃciently describe study exclusion criteria. Also,
they did not look at confounding adjustments or perform
assessment of dose-response relationships. Further, a new
study [33] was published after this meta-analysis had been
accepted for publication. Here, we conduct an updated
and more comprehensive meta-analysis of the association
between paternal smoking and childhood ALL based on
18 published studies that reported risk estimates or that
provided data to calculate risk estimates. We examined risks
associated with paternal smoking preconception, during
pregnancy and after birth and, for the ﬁrst time, analyzed
dose-response relationships of exposure in these time win-
dows.
2.Methodsand Analysis
2.1. Selection of Studies. Preliminary literature searches were
conducted by searching for the topics “smok∗” or “tobacco”
or “cigarette” and “leukemia” and “child∗”i nt h eI S IW e b
of Knowledge and PubMed databases. After duplicates were
identiﬁed and removed, the titles and abstracts of the re-
maining records were examined, and all reviews and original
epidemiologic studies investigating risk factors of childhood
leukemiawere includedforfurtherexamination onthe avail-
ability of information on paternal smoking and leukemia.
The bibliographies or citations of all relevant articles were
also searched and cross-referenced. Original epidemiologic
studies published in peer-reviewed scientiﬁc journals or
editedbooks, with data availableon bothchildhood ALLand
paternal smoking, were included.
To be included in this meta-analysis, studies had to fulﬁll
three criteria: (1) reported estimates of association (odds
ratio, OR,orrelative risk, RR)ofpaternal smoking, and ALL,
(2) reported estimates of variance (e.g., 95% conﬁdence
intervals (CI)) or included data needed to calculate it, and
(3) did not present data from the same group of subjects as
anotherpublicationusedin themeta-analysis (inwhich case,
the article with the most appropriate exposure assessment or
published most recently was selected).
2.2. Data Analysis
2.2.1. Deﬁnition of Exposure Time Windows. Based on data
available in the studies included in the analysis, three expo-
sure time windows of paternal smoking with potential rele-
vance to the development of ALL were deﬁned, that is, pre-
conception,during pregnancy andafterbirth.Summaryeﬀects
were estimated for each of these three exposure windows. To
estimate the overall summary eﬀect of paternal smoking in
any time window, the risk estimate was selected from each
study included in the following order of preference: paternal
ever smoking in lifetime, paternal smoking before concep-
tion, during pregnancy, and after birth. For the four studies
which used exposure time windows covering more than one
of these windows, the same estimate of risk was used for
all the narrower time windows falling into the wider time
window. For example, if a study presented only the relative
risk estimate for paternal smoking in the year or 12 months
prior to birth, that value was used to estimate the summary
eﬀectofbothpaternalsmokingbeforeandduringpregnancy.
In one study by Brondum et al. [21], the time window of
pregnancy was further divided into three trimesters, and
data were available only for each trimester rather than the
wholetimewindow.Sincedatawerenotavailabletocombine
the eﬀects for all the three trimesters, and the relative risk
reported for each trimester was almost the same, data from
the ﬁrst trimester was selected torepresent thistime window.
2.2.2. Selection of Outcomesand Exposure Indices. Most stud-
ies provided data on ALL speciﬁcally. In one study which
reported the risk of three immunological subtypes of ALL,
common-ALL, pre-B-ALL, and T-ALL, but not the risk of
ALLoverall,andnodatawereavailabletoestimatetheoverallJournal of Oncology 3
relative risk of ALL [43], the estimate for the most common
subtype (common-ALL, which comprised 66% of the ALL
cases in the study) was selected.
When both multipleandbinary exposure categorieswere
available,the category with the highest exposure was selected
to estimate the summary eﬀect. Although multiple exposure
indices were used in published studies, the majority of
studies used the exposure index of cigarettes per day, thus
the exposure index chosen from each study for this analysis
was in the following order of preference: cigarettes per day
(CPD), pack year (PY), number of smoking years, and
smoker/nonsmoker. When both continuous and categorical
exposure indices were available, categorical indices were
selected for the point estimate and the continuous measures
were used for dose-response analysis. When both current
and ever smoking status were available, the current smoking
status was selected.
2.2.3. Calculation of Summary Eﬀects. Both ﬁxed-eﬀect and
random-eﬀect models were used to calculate summary
eﬀects. The ﬁxed-eﬀect model uses the inverse variance
weighting method [44], and the variance (95% CI) of the
summary eﬀect estimate was calculated using the method
presented by Shore et al. [45] if the estimate on the con-
ﬁdence interval was wider than the one estimated by the
ﬁxed-eﬀect model itself. The Shore correction incorporates
between-study heterogeneity and is usually more conserva-
tive than the ﬁxed-eﬀect model in estimating the variance.
The random-eﬀect model allows for the incorporation of
between-study heterogeneity (if it is present) into the sum-
maryvarianceestimate(95%CI)[46].Resultsfromrandom-
eﬀect models were used for interpretations when between-
study heterogeneity was statistically signiﬁcant, otherwise
results from ﬁxed-eﬀect models with Shore-corrected 95%
CIs were used when the CIs were wider than the uncorrected
ones estimated by ﬁxed-eﬀect models.
2.2.4.SubgroupAnalysis. Analysiswasalsoconductedtoesti-
mate summary eﬀects for diﬀerent study subgroups, such as
those with the highest index of exposure categories, with
adjustedrisk estimates,withwell-deﬁned exposuretimewin-
dows or with population based controls, in order to investi-
gate the sensitivity of estimated summary eﬀects to factors
deﬁning the subgroups.
2.2.5. Dose Response Analysis. All studies with dose-response
data were included for review and analysis. ORs for paternal
smoking of ≥20 CPD during each time window from dif-
ferent studies were extracted, or estimated if raw data were
available,and combinedtogeta summary estimate ofORfor
paternalsmoking of≥20CPDinthistimewindow.Similarly,
summary estimates of OR for paternal smoking of 10–19
CPD or <10 CPD (<20 CPD for the time window of after
child birth) were calculated, and these summary ORs were
plotted and compared for each time window.
2.2.6. Heterogeneity Analysis. Heterogeneity among studies
was assessed using the general variance-based method as
described by Petitti [47]a n du s i n gt h eI2 [48], which de-
scribes the percentage of total variation across studies that
is due to heterogeneity rather than chance, and which is
calculated as I2 = 100%×(Q −df)/Q,w h e r eQ is Cochran’s
heterogeneity statistic and df (degrees of freedom), with
negative values of I2 set to zero. The Cochran’s heterogeneity
statistic is known to have low power of detecting true
heterogeneity when the number of studies is small, while
I2 does not inherently depend on the number of studies in
the meta-analysis [48]. Low, moderate, or high degree of
heterogeneity was suggested to be approximated by I2 values
of 25%, 50%, and 75%, respectively [48].
2.2.7. Analysis of Publication Bias. Publication bias arises
when studies with statistically signiﬁcant positive results for
exposure to environmental pollutants are more likely to be
published and cited [49]. In this meta-analysis, publication
biaswas assessed byusing funnel plotsandEgger’s andBegg’s
tests [50, 51] and by estimating the proportion of papers
which reported statistically nonsigniﬁcant risk assessments.
Funnel plots (plots of eﬀect estimates against sample
size) are usually skewed and asymmetrical in the presence
of publication bias and other biases [52]; Egger’s test [51]
is a linear regression approach to measure funnel plot
asymmetry. Begg’s test [50] assesses the interdependence of
variance and eﬀect size using Kendall’s rank correlation test.
This bias indicator makes fewer assumptions than that of
E g g e r ’ st e s t ,b u ti ti sn o ts e n s i t i v et oa sm a n yt y p e so fb i a sa s
Egger’s test. If the number of studies included for Egger’s or
Begg’s tests is small, the power of detecting publication bias
could be very low [50, 51].
All data analyses described above were conducted using
StataIC11.
3.Results
3.1. Description of Studies Included for This Updated Meta-
Analysis. Twenty-one original epidemiology studies that
examined risk factors of childhood leukemia and reported
data on both ALL and paternal smoking were found. Three
studies did not report relative risk of ALL for any index of
paternal smoking or raw data to calculate the risk [53–55],
and they were excludedfor this study. Therefore, a total of 18
studies were included in the ﬁnal analysis, and these studies
are summarized in Table 1. The studies were conducted in
8d i ﬀerent countries, and their results were all published in
peer-reviewed journals from 1990 to 2009. All studies were
case-control studies, probably because childhood leukemia
is too rare to conduct a cohort study. The age of childhood
leukemia patient inclusion varies as detailed in Table 1,w i t h
studies including cases through age 18 months (n = 1),
through age 9 years (n = 1), through age 14 years (n =
10), through age 15 years (n = 4), through age 18 years
(n = 1), orunspeciﬁed with mean age 6.1 years and standard
deviation 3.6 years for cases and mean age 6.6 years and
standard deviation 3.5 years for controls (n = 1). Controls
were recruited from the general population in all but three
studies which used hospital-based controls [29, 31, 42]. All4 Journal of Oncology
Table 1: Description of the 18 original research studies on paternal smokingand childhood ALL included in the meta-analysis.
Study Cases/controls Age
(years) Case recruitment Control selection Overall∗ Before
pregnancy
During
pregnancy After birth
Lee et al. 2009,
Korea [42] 106/164 0–18
Incident childhood
leukemia cases
diagnosed in three
hospitals in Seoul
between 2003 and
2005
Other patients
from the three
hospitals where
cases came from,
matched for age
and sex
≥400
cigarettes/life
time
number of
PYs, ≤10 or
>10 PYs
smoking at
home
during
pregnancy
number of
PYs, ≤10 or
>10 PYs
Rudant et al.
2008, France
[33]
647/1681 <15
Cases were identiﬁed
directly by
investigators with
support of the
national cancer
registry in France
between 2003 and
2004
Population based,
with quota match
for age and sex
CPDs from
the year
prior to the
child’s birth
to the
interview
CPDs from
the year
prior to the
child’s birth
to the
interview
CPDs from
the year
prior to the
child’s birth
to the
interview
MacArthur et
al. 2008,
Canada [28]
351/399 0–14
Incidence case from 5
regions in Canada,
diagnosed between
1990 and 1994
From health
insurance roll,
matched for age,
sex, and area for
each case
ever smoker
CPDs
before
pregnancy
CPDs in the
year prior to
the child
birth
Menegaux et al.
2007, France
[30]
407/567 <15
Cases derived from
the national registry
in 14 regions between
1995 and 1998
Population based,
frequency match
for age, sex, and
area
CPDs in the
3m o n t h s
before
pregnancy
CPD from
the child’s
birth to the
diagnosis
Chang et al.
2006, USA [23] 228/306 ≤15
hospital diagnosed
cases between 1995
and 2002, North
California Childhood
Leukemia Study
Random selection
from birth
certiﬁcates,
individual match
for age, sex, and
maternal race
ever smoker:
≥100 cigs
before
diagnosis
CPD in the
3m o n t h s
before
pregnancy
Menegaux et al.
2005, France
[31]
240/142 <15
newly diagnosed
acute leukemia cases
from 1995 to 1999 in
four cities in France
Mostly from
departments of
orthopedic of the
same hospital,
matched for age
range
CPDs from
the index
birth to
interview
Pang et al. 2003,
England [32] 1375/6987 <15
National wide
population-based
cancer cases
diagnosed by regional
oncology units
between 1991–1994
in Scotland and
1992–1994 in
England
Randomly selected
from Family
Health Serves
Authorities lists,
and matched for
sex, date of birth,
and geographical
area of residence
ever smoked
before
conception
Sorahanet al.
2001, England
[37]
139/132 <15
Children ﬁrst
diagnosed with
leukemia in 3 areas in
England in
1980–1983§
From General
Practitioners list,
matched for sex
and date of birth
CPDs
Infante-Rivard
et al. 2000,
Canada [26]
486/486 0–9
Cases from tertiary
care centers for
childhood cancers,
diagnosed in
1980–1993, Quebec
Population based
from family
allowance,
matched for age,
sex, and area
CPDs
between
birth and
date of
diagnosisJournal of Oncology 5
Table 1: Continued.
Study Cases/controls Age
(years) Case recruitment Control selection Overall∗ Before
pregnancy
During
pregnancy After birth
Brondum et al.
1999, USA [21] 1618/1986 <15
Newly diagnosed with
leukemia via clinical
trial registries from
1989 to 1993, CCG
study
RDD, individually
matched on age,
race, area code
and exchange
smoking
amounts
during
lifetime
ever smoked
one month
before
pregnancy
ever smoked
during the
three
trimesters
ever smoked
during
nursing
period
Schuz et al.
1999, German
[43]
686/2588 <15
From a nationalwide
cancer registry
(1992–1997) and
from cases diagnosed
(1980–1994) and
lived in vicinity of
nuclear installations
randomly selected
from complete
ﬁles of local oﬃces
of registration of
residents, matched
for area, sex, and
similar date of
birth (within one
year)
CPDs in the
last 3
months
before
pregnancy
Sorahanet al.
1997b, England
[38]
573/573 <16
Children who died
from leukemia in
England, Wales, and
Scotland between
1971 to 1976
From birth
registers of local
authority areas
where cases died,
matched by sex
and date of birth
current
status, 6
levels from 0
to 40 CPD
Sorahanet al.
1997a, England
[36]
367/367 <16
Children who died
from leukemia in
England, Wales, and
Scotland between
1953 to 1955
From birth
registers of local
authority areas
where cases died,
matched for sex
and date of birth
current
status, 4
levels from 0
to 20 CPD
Ji et al. 1997,
China [41] 114/114 <15
Newly diagnosed
childhood cancer
cases from 1985 to
1991 in Shanghai
Population-based
controls from
household
registry, matched
for sex, and year of
birth
PYs before
conception
PYs after
birth
Shu et al. 1996,
USA, Canada
[34]
191/363
≤18
months
infants newly
diagnosed matched
for leukemia from
1983 to 1988 via
clinical trial registries
RDD, individually
matched for year
of birth, telephone
area code, and
exchange number
CPDs in the
monthprior
to
pregnancy
CPDs
during
pregnancy
Sorahanet al.
1995, England
[35]
371/371 <16
Children who died
from leukemia in
England, Wales, and
Scotland between
1977 to 1981§
From the birth
register of the
local authority
area in which the
case child died,
matched for sex
and date of birth
CPDs
during
prenatal
period,
categorized
into 6 levels
John et al. 1991,
USA [27] 47/184 0–14
Incident cases aged
0–14 diagnosed in
Denver, Colorado
from 1976 to 1983
RDD, matched on
age, sex, and
geographic area.
CPDs
during the
12 months
prior to
birth
CPDs
during the
12 months
prior to
birth
Magnani et al.
1990, Italy [29] 142/307 6.1/6.6#
Pediatric hospital
prevalent cases in
Turin Italy, diagnosed
between 1974 and
1984
Randomly
sampled from
medical or
surgical wards of
the same hospitals,
no matches
CPDs up to
child’s birth
CPDs up to
child’s birth
RDD: random digit dialing; CPD: cigarettes per day; PY: package year; ∗: overall statusmeans without speciﬁc exposure time period speciﬁed; §:T h e r ew a sa
small degree of overlap between cases included by Sorahan et al. 2001 [37] and cases included by Sorahan et al. 1995 [35]; #: mean age of cases at diagnosis:
6.1 years, with standard deviation of 3.6 years and mean age of controls: 6.6 years, with standard deviation of 3.5 years.6 Journal of Oncology
studies except the one by Magnani et al. 1990 [29]m a t c h e d
controls and cases by age and most studies also matched
by gender and area of residency. Exposure information on
paternalsmokingwas obtainedprimarily byinterviewing the
mother (11 studies [23, 29–36, 38, 42]), while the remaining
studies interviewed both parents, when possible.
Three studies reported childhood ALL risks in relation
to parental use of tobacco [35, 36, 38] using data from the
same large project called the Oxford Survey of Childhood
Cancers (OSCC). This survey interviewed the parents of all
children who died of cancer (including leukemia) before
their sixteenth birthday in England, Wales, and Scotland
during the period 1953 to 1984 and parents of population-
based healthy control children, matched for sex and date
of birth [35, 36, 38]. Because each of the three papers
reported results from diﬀerent and non-overlapping subsets
of data, they were regarded as independent and were all
included in the meta-analysis. There was, however, a small
degree of overlap between cases included by Sorahan et al.
1995 [35] from the OSCC and cases included by Sorahan
et al. 2001 [37]. The later publication included 139 newly
diagnosed childhood ALL cases less than 15 years old in
three areas in England from 1980 to 1983 [37], and the early
paper included 371 children who died from ALL before their
sixteenth birthday in England, Wales, and Scotland between
1977 to 1981 [35]. Thus, there is potential overlap between
newly diagnosed ALL cases and those who died from ALL
during 1980-1981. Given the high ﬁve-year survival rate of
childhood ALL during that time period in England (about
50%) [56], such an overlap would be expected to be very
small in this 2 year period, thus, both the Sorahan et al.
studies [35, 37] were included in this analysis.
Of the18 studiesincludedinthe analysis, 6 reported data
on the risk of childhood ALL associated with paternal ever-
smoking throughout the lifetime [21, 23, 28, 36, 38, 42]. The
summary eﬀects of paternal smoking preconception, during
pregnancy and after the child birth could be estimated from
13 studies, 8 studies and 7 studies, respectively. Menegaux
et al. 2005 [31] reported that paternal smoking was not
associated with ALL either before or during pregnancy, but
did not provide the actual data. However, they did report
data on the association during the period from the child
birth to the interview. Thus, the Menegaux study (2005) was
included to calculate the summary eﬀects of exposure after
birth only.
3.2. Estimates of Summary Eﬀects, Subgroup Analysis and
Heterogeneity Analysis
3.2.1. Overall and Lifetime Paternal Smoking. Results of the
meta-analysis are presented in Figure 1 and Table 2. Figure 1
graphs the ORs (random eﬀects analysis) generated by each
meta-analysis and the ORs and weights of the individual
studiesincludedtherein. Table 2 detailsthe summary relative
eﬀects of paternal smoking overall and during speciﬁc time
windows, and for diﬀerent subgroups within these exposure
windows, using both ﬁxed eﬀect and random eﬀect models.
The degree of heterogeneity associated with each measure is
also provided.The summary eﬀectforpaternal eversmoking
at any time period was 1.11 (95% CI: 1.05–1.18, I2 = 18%)
based upon all 18 studies, shown in Figure 1(a) and Table 2.
When analysis was restricted to the data from six studies
on overall lifetime paternal smoking status, only, not during
speciﬁc exposure windows, the summary eﬀect decreased
from 1.11 to 1.07 (95% CI: 1.01–1.14, I2 = 0%).
3.2.2. Preconception Paternal Smoking. The summary OR
for risk of ALL associated with preconception smoking was
1.25 (95% CI: 1.08–1.46, I2 = 53%) based on 13 studies
(Figure 1(b) and Table 2). When only the highest exposure
indices available in 10 studies were included, the summary
eﬀect increased to 1.38 (95% CI: 1.11–1.72, I2 = 45%,
Table 2). Exclusion from the analysis of studies with the
largestorsmallestOR,thosewiththehighestweight,orthose
with hospital-based controls, did not have a large impact
on either the summary eﬀect estimates or the heterogeneity.
Both the summary eﬀect and the heterogeneity between
studies decreased (1.17, 95% CI: 1.02–1.35, I2 = 33%) after
removing studies with exposure time windows that spanned
more than those deﬁned in our analysis (with wide deﬁned
exposure time windows hereafter, for example, the year prior
to the child’s birth to the time of interview [33], 12 months
prior to the child birth [27], or up to child’s birth [29]).
Exclusion of Rudant et al. 2008 [33] alone, whose estimated
eﬀect (OR = 1.7; 95% CI: 1.3–2.1) was for the highest
paternal smoking ≥20 cigarettes/day from the year prior
to the child birth to the time of interview, had a similar
summary eﬀect on OR and heterogeneity as removing all 3
studies with wide deﬁned exposure windows. Five studies
reported the eﬀect of paternal smoking speciﬁcally in the
last one or three months before pregnancy [21, 23, 30, 34,
43], and their summary OR was 1.13 (95% CI: 0.98–1.29)
with no evidence of heterogeneity between studies (I2 =
0%).
3.2.3. Paternal Smoking during Pregnancy. Children whose
fathers smoked while they were in utero had a 24% higher
relative risk of getting ALL than those whose father did
not smoke (summary OR = 1.24, 95% CI: 1.07–1.43,
I2 = 54%), shown in Figure 1(c) and Table 2.W h e no n l y
the highest exposure indices available in four studies were
included, the summary eﬀect was 1.28 (95% CI: 0.93–1.76,
I2 = 65%). Inclusion of only studies with adjusted ORs
also increased the summary eﬀect (summary OR = 1.34,
95% CI: 1.07–1.68, I2 = 60%). In contrast, when only
studies with well-deﬁned exposure time windows (during
pregnancy) were included, the summary eﬀect decreased to
1.15 (95% CI: 1.06–1.23, I2 = 0%). Exclusion of Rudant et
al. 2008 [33] alone, which estimated the eﬀect (OR = 1.7;
95% CI: 1.3–2.1) for the highest paternal smoking of ≥20
CPD from the year prior to the child birth to the time of
interview, had a similar eﬀect on OR and heterogeneity as
removing all 3 studieswith widely deﬁned exposure window.
Removing extreme ORs, studies with the highest weight or
with hospital-based controlshad littleeﬀect on the summary
estimates (Table 2).Journal of Oncology 7
Table 2: Results of meta-analysis of paternal smoking in diﬀerent time periods and childhood acute lymphoblastic leukemia (ALL) risk.
Paternal smokinga Studies included N
Fixed-eﬀect modelb Random-eﬀect model I2c
OR
(95% CIs) P OR
(95% CIs) P (%)
Paternal ever smoking [21, 23, 26–38, 41–43]1 8 1.11
(1.05, 1.16) .000 1.11
(1.05, 1.18) .000 18
Overall lifetime ever smokingd [21, 23, 28, 36, 38, 42]6 1.07
(1.01, 1.14) .027 — — 0
Preconception [21, 23, 27–30, 32–
34, 37, 41–43] 13 1.16
(1.03, 1.31) .016 1.25
(1.08, 1.46) .002 53
With the highest exposure index [27–30, 33, 34, 37, 41–43]1 0 1.37
(1.13, 1.66) .001 1.38
(1.11, 1.72) .004 45
Removing the smallest and greatest ORs [21, 23, 27, 28, 30, 32–
34, 41–43] 11 1.16
(1.03, 1.31) .013 1.25
(1.08, 1.46) .003 50
Removing the two greatest ORs [21, 23, 27–30, 32–
34, 37, 41–43] 11 1.15
(1.03, 1.28) .013 1.20
(1.05, 1.36) .003 41
Removing the highest weighte [21, 23, 27–
30, 33, 34, 37, 41–43] 12 1.25
(1.08, 1.45) .003 1.31
(1.10, 1.56) .003 49
Removing the OR from Rudant, 2008f [21, 23, 27–30, 32–
34, 37, 41–43] 12 1.10
(1.00, 1.22) .060 1.15
(1.01, 1.31) .03 26
With well-deﬁned exposure periodg [21, 23, 28, 30, 32, 34, 37,
41–43] 10 1.11
(0.99, 1.23) .069 1.17
(1.02, 1.35) .026 33
With paternal smokingduring 1 or 3
months before pregnancy [21, 23, 30, 34, 43]5 1.13
(0.98, 1.29) .085 — — 0
With population-based controls [21, 23, 27, 28, 30, 32–
34, 41, 43] 10 1.16
(1.02, 1.31) .020 1.25
(1.07, 1.45) .005 54
During pregnancy [21, 27–29, 33–35, 42]8 1.19
(1.07,1.32) .001 1.24
(1.07,1.43) .004 54
With the highest exposure index [27–29, 33]4 1.34
(1.02, 1.77) .037 1.28
(0.93, 1.76) .13 65
With adjusted ORs [21, 27, 28, 33, 34, 42]6 1.26
(1.04, 1.51) .017 1.34
(1.07, 1.68) .010 60
Removing the smallest and greatest ORs [21, 27, 28, 33–35]6 1.19
(1.06, 1.33) .002 1.25
(1.07, 1.45) .003 58
Removing the highest weighth [21, 27–29, 33, 34, 42]7 1.23
(1.03,1.47) .022 1.28
(1.04,1.58) .022 59
Removing the OR from Rudant, 2008 [21, 27–29, 34, 35, 42]7 1.15
(1.06, 1.23) .000 — — 0
With well-deﬁned exposure periodi [21, 34, 35, 42]41.15
(1.07, 1.25) .002 1.16
(1.03, 1.31) .015 25
With population-based controls [21, 27, 28, 33–35]6 1.19
(1.06, 1.33) .002 1.25
(1.07, 1.45) .003 58
After birth [21, 26, 30, 31, 33, 41, 42]7 1.20
(0.97, 1.49) .092 1.24
(0.96, 1.60) .092 64
With the highest exposure index [26, 30, 31, 33, 41, 42]6 1.35
(1.06, 1.72) .008 1.33
(1.00, 1.78) .05 57
Removing the smallest and greatest ORs [26, 30, 31, 33, 41]5 1.32
(1.03, 1.70) .027 1.27
(0.95, 1.68) .10 58
Removing the highest weightj [26, 30, 31, 33, 41, 42]6 1.35
(1.06, 1.72) .008 1.33
(1.00, 1.78) .05 578 Journal of Oncology
Table 2: Continued.
Paternal smokinga Studies included N
Fixed-eﬀect modelb Random-eﬀect model I2c
OR
(95% CIs) P OR
(95% CIs) P (%)
Removing the OR from Rudant, 2008 [21, 26, 30, 31, 41, 42]5 1.05
(0.89, 1.23) .58 1.06
(0.89, 1.26) .25 12
With population-based controls [21, 30, 31, 33, 41]5 1.23
(0.96, 1.59) .11 1.25
(0.92, 1.69) .15 68
aWhen multiple indices of exposure categories were available, the highest was selected to estimate the summary eﬀects; otherwise, the binary category was
selected, except for the analysisof the subgroup with highest exposure;
b95% conﬁdence interval (CI) and P values were estimated by Shore correction when they were wider or greater than the unadjusted estimatesby ﬁxed-eﬀect
models. The Shore correction incorporates interstudyheterogeneity;
cI2 = 100%×(Q−df)/Q, where Q is Cochran’s heterogeneity statisticand df the degrees of freedom, with negative values of I2 put equalto zero. I2 describes
the percentage of total variation across studies that is due to heterogeneity rather than chance
dOnly included studies that reported an association between childhood ALL and paternal overall smoking status during lifetime
eRemoved the OR from Pang et al. 2003, which accounted for 42% of the weight;
fRudant et al. 2008 reported risk of childhood ALL for paternal smoking one year before the child birth to the time of interview; the same estimated risk was
used for calculating the summaryeﬀect of childhood ALL for paternal smoking before conception, during pregnancy and after birth.
gOnly included ORs for paternal smoking before pregnancy, removed the ORs from Rudant et al. 2008, John et al. 1991 and Magnani et al. 1990, which
estimated ORs for paternal smoking in the year (12 months) before birth, preconception, and during the prenatal period;
hRemoved the OR from Sorahan et al. 1995, which accounted for 70% of the weight;
iOnly included ORs for paternal smoking during pregnancy and excluded ORs for paternal smoking during the year (or 12 months) prior to birth.
jRemoved the OR from Brondum et al. 1999, which accounted for 35% of the weight.
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Sorahan et al, 1997a [36]
Chang et al. 2006 [23]
Sorahan et al, 1995 [35]
Infante-Rivard. et al, 2000 [26]
Lee et al. 2009 [42]
Shu et al. 1996 [34]
Pang et al. 2003 [32]
John et al. 1991 [27]
Brondum, et al. 1999 [21]
Rudant et al. 2008 [33]
Study
1.11 (1.06, 1.16)
1.00 (0.66, 1.51)
1.06 (0.77, 1.46)
0.90 (0.57, 1.42)
1.10 (0.80, 1.51)
ratio (95% CI)
1.07 (0.99, 1.16)
1.20 (0.71, 2.03)
3.80 (1.24, 11.69)
5.29 (1.31, 21.33)
1.08 (0.91, 1.28)
1.25 (0.85, 1.83)
1.16 (1.06, 1.27)
1.00 (0.73, 1.36)
1.30 (0.70, 2.41)
1.51 (0.82, 2.78)
1.04 (0.91, 1.18)
1.60 (0.67, 3.82)
1.06 (0.90, 1.25)
1.40 (1.13, 1.74)
Odds
100.00
1.18
1.98
0.96
2.05
Weight
32.21
0.73
0.16
0.10
7.28
1.40
24.76
2.11
0.53
0.55
11.98
0.27
7.49
4.27
(%)
0.5 1 1.5 2 2.5 5 10
Overall
(I-squared = 18.4%, P = .234)
Sch¨ uz et al, 1999 [43]
(a) ever smoking
Note: weights are from random effects analysis
John et al. 1991 [27]
MacArthur et al. 2008 [28]
Shu et al. 1996 [34]
Sorahan et al. 2001 [37]
Magnani et al. 1990 [29]
Ji et al. 1997 [41]
Pang et al. 2003 [32]
Brondum et al. 1999 [21]
Chang et al. 2006 [23]
Menegaux et al. 2007 [30]
Lee et al. 2009 [42]
Study
ID
Rudant et al. 2008 [33]
1.25 (1.08, 1.46)
1.60 (0.67, 3.82)
1.15 (0.79, 1.67)
1.51 (0.82, 2.78)
5.29 (1.31, 21.33)
0.90 (0.57, 1.42)
3.80 (1.24, 11.69)
1.04 (0.91, 1.18)
1.10 (0.80, 1.51)
1.07 (0.90, 1.27)
1.35 (0.86, 2.11)
1.20 (0.71, 2.03)
1.60 (0.76, 3.35)
Odds
ratio (95% CI)
1.70 (1.34, 2.16)
100.00
2.69
9.04
4.82
1.15
7.14
1.71
17.03
10.73
15.60
7.38
5.96
3.56
Weight
13.19
(%)
Overall
(I-squared = 53.6%, P = .011)
0.5 1 1.5 2 2.5 5 7.5
Sch¨ uz et al, 1999 [43]
(b) preconception smoking
Note: weights are from random effects analysis
MacArthur et al. 2008 [28]
Brondum et al. 1999 [21]
ID
Rudant et al. 2008 [33]
Shu et al. 1996 [34]
John et al. 1991 [27]
Sorahan et al, 1995 [35]
Magnani et al. 1990 [29]
Lee et al. 2009 [42]
Study
1.24 (1.07, 1.43)
1.12 (0.85, 1.48)
1.06 (0.89, 1.26)
ratio (95% CI)
1.70 (1.34, 2.16)
1.45 (0.96, 2.20)
1.60 (0.67, 3.82)
1.16 (1.06, 1.27)
0.90 (0.57, 1.42)
2.10 (0.90, 4.90)
Odds
100.00
14.38
20.96
16.48
8.61
2.54
26.84
7.52
2.67
Weight
(%)
Overall (I-squared = 53.8%, P = .034)
0.5 1 1.5 2 2.5 5
(c) smoking during pregnancy
Note: weights are from random effects analysis
Menegaux et al. 2007 [30]
Menegaux et al. 2005 [31]
Ji et al. 1997 [41]
Rudant et al. 2008 [33]
Brondum et al. 1999 [21]
Lee et al. 2009 [42]
Infante-Rivard et al, 2000 [26]
1.24 (0.96, 1.60)
1.30 (0.77, 2.20)
1.00 (0.66, 1.51)
1.80 (0.59, 5.45)
1.70 (1.34, 2.16)
0.98 (0.79, 1.22)
3.00 (1.01, 8.90)
1.00 (0.73, 1.36)
100.00
12.39
15.64
4.39
21.58
22.35
4.53
19.12
ID
Study
ratio (95% CI)
Odds Weight
(%)
Overall (I-squared = 64.4%, P = .01)
0.5 1 1.5 2 2.5 5
(d) smoking after birth
Figure 1: Meta-analysis of the association between childhood ALL and paternal smoking in diﬀerent time windows. Random-eﬀect OR
estimates and weights were used in the graphs. X-axis represent the OR (odds ratio). The sizes of the boxes indicate the weight of the corre-
sponding study used for estimates of summary eﬀects.Journal of Oncology 9
Table 3: Summary of the ﬁve studies distinguishing the eﬀects of paternal and maternal smokingon childhood ALL.
Study
Exposure to parental smoking Number of
case/control OR (95% CI) Adjustments
Paternal smoking Maternal smoking
Lee et al. 2009, Korea [42]∗
Ever smoked cigarettes
Adjusted for age,
sex, birth weight,
father’s education
Lifetime nonsmokers Lifetime nonsmokers 22/41 reference
ever lifetime nonsmokers 84/122 1.3 (0.7, 2.4)
pack-years before pregnancy
0 lifetime nonsmokers 22/41 reference
≤10 lifetime nonsmokers 48/60 1.6 (0.8, 3.1)
>10 lifetime nonsmokers 28/33 1.6 (0.8, 3.5)
Smokingat home during
pregnancy
Lifetime nonsmokers lifetime nonsmokers 22/41 reference
yes lifetime nonsmokers 22/22 2.1 (0.9, 4.9)
pack-years after birth
0 lifetime nonsmokers 27/55 reference
≤10 lifetime nonsmokers 64/77 1.7 (0.9, 3.1)
>10 lifetime nonsmokers 11/11 3.0 (1.0,8.8)
Ji et al. 1997, China [41]
pack-years before pregnancy
Adjusted for birth
weight, income,
paternal age,
education, and
alcohol drinking
0 lifetime nonsmokers — reference
≤2 lifetime nonsmokers — 0.8 (0.2–2.5)
2 to 5 lifetime nonsmokers — 1.0 (0.4–2.7)
≥5 Lifetime nonsmokers — 3.8 (1.3–12.3)
Pack-years after pregnancy
0 lifetime nonsmokers — reference
≤2 lifetime nonsmokers — 1.1 (0.4, 2.8)
2 to 5 lifetime nonsmokers — 1.8 (0.6, 5.2)
≥5 lifetime nonsmokers — 1.8 (0.6, 5.5)
Chang et al. 2006, USA [23]
No preconception smoking no postnatal smoking 144/205 reference Adjusted for
household income
and maternal
smokingduring
preconception
and pregnancy
No preconception smoking postnatal smoking 8/27 0.72 (0.22,2.38)
Preconception smoking no postnatal smoking 36/47 0.88 (0.51,1.52)
Preconception smoking postnatal smoking 37/23 3.94
(1.25,12.37)
Brondum et al. 1999, USA [21]
Never smoked in the home never smokingin
the home — reference Adjusted for
household income,
mother’s and
father’s race and
education
Never smoked in the home ever smoked in
the home — 1.10 (0.88, 1.38)
Ever smoked in the home never smokingin
the home — 1.04 (0.86, 1.26)
Ever smoked in the home ever smoked in
the home — 1.09 (0.91, 1.30)
John et al. 1991, USA [27]
Not during the year prior to
birth
not during the 1st
trimester — reference
Adjusted for
father’s education Not during the year prior to
birth
yes, during the 1st
trimester — 1.9 (0.9, 4.1)
Yes, during the year prior to
birth
not during the 1st
trimester — 1.4 (0.6, 3.1)
Yes, during the year prior to
birth
yes, during the 1st
trimester — 1.8 (0.8, 4.0)
∗It was reported that small portion of mothers smoked (the smoking rate was 6.1% for controls’ mothers; it was not reported for cases’ mothers).10 Journal of Oncology
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Figure 2: Begg’s funnel plots of the natural log odds ratio (ln(OR)) versus the standard error of the log odds ratio (s.e of ln(OR)) of the
studies used in the meta-analysis. Random-eﬀect model OR estimates were used in the graphs. The sizes of the circles indicate the inverse-
variance weight of the corresponding study.
3.2.4. Paternal Smoking after Birth. Paternal smoking after
birth also had a positive but borderline signiﬁcant asso-
ciation with childhood ALL (OR = 1.24; 95% CI: 0.96–
1.60, I2 = 64%), shown in Figure 1(d) and Table 2.
Little diﬀerence was observed in the summary eﬀects when
removing extreme ORs or hospital-based studies (Table 2).
When only studies with the highest exposure indices were
included, or the study with the highest weight was excluded,
the summary OR increased to 1.33 (95% CI: 1.00–1.78, I2 =
57%). As with the other exposure windows, exclusion of
Rudantet al. 2008alone, reduced the OR,in thiscase, to 1.06
(95% CI: 0.89–1.26) and the heterogeneity to 12%.
3.3. Eﬀect of Adjustment for Confounding Factors. One study
[38] reported unadjusted RR, and two studies [35, 36]d i d
not clarify whether they had adjusted for any other variables
in their eﬀect estimates. All remaining studies adjusted for
at least some index of social economic status, for example,
incomeorparentaleducation,andmoststudies alsoadjusted
for other potential confounders including residential area,
birth weight, parental age and/or race/ethnicity, and alcohol
drinking during pregnancy. For preconception paternal
smoking, eight studies [23, 27, 28, 30, 33, 34, 37, 42]
presented numbers of cases and controls with or without
exposure allowing for the calculation of crude ORs. The
current meta-analysis on these eight studies showed that the
summary OR of the calculated crude ORs was 1.46 (95% CI:
1.18–1.80) and the summary OR of the reported ORs with
adjustment was 1.37 (95% CI: 1.09–1.71).
3.4. Analysis of Publication Bias. For preconception paternal
smoking, the P values for Begg’s and Egger’s tests were 0.035
and 0.007, respectively, which, together with the funnel plots
(Figure 2(b)), suggest some evidence of publication bias.
This might be due to the inclusion of two relatively smaller
studies with greater ORs and variance of estimates [37, 41].
Ji et al. 1997 [41] reported an OR of 3.8 (95% CI: 1.3–12.3)
for children whose fathers smoked for 5 pack years before
conception; Sorahan et al. 2001 [37] reported an OR of 5.29
(95% CI: 1.31–21.3) for paternal smoking with ≥40 CPD
before pregnancy. Removal of these two studies resulted in a
P value of 0.24 for Begg’s test and 0.07 for Egger’s test, while
the summary eﬀect did not change much (random-eﬀect
model, summary OR = 1.20, 95% CI: 1.05–1.36, P = .007,
I2 = 41%). Similar publication bias test results were found
for paternal ever smoking in any time period, most likelyJournal of Oncology 11
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Figure 3: Clear positive dose-response associations between paternal smoking and childhood ALL found from the literature. Note: Among
all the 18 studies included in this meta-analysis, two did not present dose-response analysis [32, 43], 10 did not ﬁnd clear dose-response
trend, and the remaining six studies reported clear dose-response trends [23, 33, 35, 37, 41, 42], which were presented in this ﬁgure. CPD:
cigarettes per day; PY: pack years; the ﬁgure for Chang et al. 2006 [23] was estimated from their report that, for paternal preconception
smoking, an OR of 1.03 (95% CI: 1.00–1.06) was associated with a one-CPD increment, and an OR of 1.34 (95% CI: 1.02–1.74) with 10-
CPD increment, and the ﬁgure for Sorahanet al.1995 [35] was estimated from their report of an OR of 1.16(95% CI: 1.06–1.27) for change
of one level of prenatal use of tobacco products.
because the same estimates from the Ji et al. 1997 [41]a n d
Sorahan et al. 2001 [37] were included, Figure 2(a).
BothBegg’sand Egger’stests showed no evidenceof pub-
lication bias for studies on paternal smoking during preg-
nancy and after child birth (both with P value >. 1), though
the power to detect publication bias might be lower because
of the smaller number of studies included compared with
preconception exposures, Figures 2(c) and 2(d). Neverthe-
less, the fact that only eight of the 18 studies included
reported any statistically signiﬁcant eﬀect of paternal smok-
ing on childhood ALL risk further indicates that the proba-
bility of publication bias is small.
3.5. Dose Response Analysis. Among the 18 studies included
in this updated meta-analysis, two studies did not present
dose-response analysis [32, 43] and 10 did not ﬁnd signiﬁ-
cant dose-response relationships between paternal smoking
and childhood ALL. Data from the remaining six studies
[23,33,35,37,41,42]thatpreviouslyreported positivedose-
response relationships are summarized in Figure 3.T h e s e
data indicate that dose-response eﬀects may occur before
conception, during the prenatal period, or after birth.
We calculated the summary eﬀects for exposure to dif-
ferent levels of paternal smoking during each of the three
time windows, as shown in Figure 4.D a t as h o w e dap o s i t i v e
dose-response relationship between childhood ALL and
preconception paternal smoking, with a summary OR of
1.17 (95% CI: 0.9–1.54), 1.25 (95% CI: 1.01–1.55) and 1.30
(95% CI: 1.09–1.55), for paternal smoking of <10, 10–19,
and ≥20 CPD, respectively. For paternal smoking during
pregnancy, no dose-response relationship was found. For
paternal smoking ≥20 CPD after birth, the summary eﬀect
was 1.24 (95% CI: 0.91–1.68), compared to the summary
eﬀect of 1.12 (95% CI: 0.83–1.51) for smoking <20 CPD.
4.Discussion
4.1. Association of Paternal Smoking and Childhood ALL.
More than half of the studies included in this analysis
reported relative risk estimates that were not statistically
signiﬁcant; one possible reason for this may be that a true
association exists, but these studies did not have the sample
sizes or statistical power to identify statistically signiﬁcant
associations. This is not surprising given the relatively low
summary ORs we identiﬁed (i.e., <1.4) and the large sample
sizes required toidentify ORsofthismagnitude inindividual
studies. Meta-analysis can increase study power by pooling
all published data. The literature review and meta-analysis12 Journal of Oncology
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Figure 4: Evaluation of dose-response relationships between paternal smokingat diﬀerent time windowsand childhood ALL risk.Estimates
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reported here, which incorporates more studies (n = 18)
than previous reviews and ﬁnds positive dose-response
relationships for exposure to paternal smoking before preg-
nancy and after child birth, supports statistically signiﬁcant
association between paternal smoking and childhood ALL.
The International Agency for Research on Cancer (IARC)
reviewed 6 studiespublished up until 2000in 2004, and their
meta-analysis for paternal smoking “indicated no statistically
signiﬁcant association with acute lymphocytic leukaemia”
[18]. The Surgeon General Report 2006 [20]r e v i e w e d1 0
epidemiology studies on parental smoking and childhood
leukemia published from 1990 to 2001 and concluded that
“T h ee v i d e n c ei ss u g g e s t i v eb u tn o ts u ﬃcient to infer a
causal relationship between prenatal and postnatal exposure
to secondhand smoke and childhood leukemia.”T h i sr e p o r t
did not examine risk of ALL speciﬁcally. The California EPA
also updated its review on parental smoking and childhood
acute leukemia in its 2005 report [57], which included 13
studies and concluded that “evidence to date is suggestive of
an association between preconceptional paternal smoking and
leukemia risk, but not postconceptional ETS (environmental
tobacco smoke) exposure.” These conclusions were all made
on overall childhood leukemiaincludingboth ALL and AML
and did not diﬀerentiate the potential eﬀect of paternal
smoking on childhood ALL speciﬁcally.
A recent meta-analysis by Lee et al. [42], based on 12
studies, found that the risk of childhood ALL increased with
overall paternal smoking (OR = 1.07, 95% CI: 1.00–1.14,
n = 5) and smoking before pregnancy (OR = 1.17, 95% CI:
1.04–1.30, n = 9) but not after birth. This research group
did not evaluate risk during pregnancy. In contrast, in our
current meta-analysis, overall lifetime paternal smoking and
smoking preconception, during pregnancy and after birth,
were all positively associated with childhood ALL. Further,
positivedose-response relationships werefoundforexposure
to paternal smoking before pregnancy and after child birth.
Our ﬁndings, and those of Lee, strengthen the association
of paternal smoking and childhood ALL overall, particularly
preconception,while the eﬀectofSHSduring pregnancy and
after birth on ALL risk requires further conﬁrmation.
4.2. Limited but Possible Confounding and Bias. We assessed
the strength of the observed associations in several ways. In
general, moderate heterogeneity (I2 ≈ 50%) was observed
among studies. Selection bias was assessed by comparing
summary eﬀects estimated from all studies with those from
studies including population-based controls only and was
found to be minimal. Most studies analyzed matched cases
and controls for gender and age and adjusted for SES and
other potential confounders. Comparison of the summary
eﬀectsofadjustedORswith thoseofcrudeORsin eightstud-
ies suggested that the adjustment of confounding does not
impact the data but it is possible that some unmeasured orJournal of Oncology 13
residual confounders could have contributed to the observed
eﬀects.
Information bias is another potential issue as most of the
studies collected data on paternal smoking from the child’s
mother, who might not be able to provide accurate informa-
tion on the exposure. However, because the same approach
was used for both cases and controls, information bias
from this source was probably nondiﬀerential and would
likely bias the estimates towards null. Another source of
information bias, recall bias, could arise from parents of
cases being more likely to recall an exposure than parents of
controls.However,smokingisnotgenerallydiﬃculttorecall,
so that recall bias is less likely than in studies of exposure to
other environmental agents.
Both Egger’s and Begg’s tests indicated the probability
of publication bias for paternal smoking before pregnancy,
apparently due to inclusion of two studies [37, 41]. Ji et al.
1997[41] studiedthe eﬀectofpaternalsmoking forrelatively
longer periods or at higher exposures before conception
(5 pack years before the conception); also, they obtained
the exposure information by independent interviews with
subjects’fathers andmotherssothattheexposureassessment
from this paper might be less biased than that from other
studies. Sorahan et al. 2001 [37]e x a m i n e dt h ee ﬀect of
paternal smoking with ≥40 CPD before conception, while
the other studies generally used ≥20 CPD as their highest
exposure group. Thus, the asymmetric funnel plot does not
necessarily indicate evidence of publication bias, but may
indicate possible heterogeneity or dose-response eﬀects. The
fact that many nonsigniﬁcant associations were published
(56% of studies included in the current review) further
indicates that the probability of publication bias is small or
limited.
Maternal smoking is another potentially important con-
founding factor for the association between paternal smok-
ing and childhood ALL. As data on maternal smoking was
not adjusted in many of the studies included here, we were
unable to estimate the summary eﬀects of paternal smoking
with complete adjustment for maternal smoking. However,
the two studies in Asia [41, 42] were conducted in regions
with very low smoking rates among women; in one study,
none of the mothers of cases or controls smoked [41]; in
the other study, only 6% of control mothers smoked [42],
both reported positive associations (though not all were
signiﬁcant) between paternal smoking during some time
windows and at higher levels of exposures and childhood
ALL risk (Table 3). Three American studies [21, 23, 27],
which examined both paternaland maternal smoking, found
noevidenceofanincreased riskforexposuretoonlypaternal
smoking or only maternal smoking. But one study [23]
found a signiﬁcantly increased ALL risk for exposures to
both parents’smoking (paternalpreconceptionsmoking and
maternal smoking after birth). These ﬁve studies are detailed
in Table 3. Since most of the studies on maternal smoking
and childhood ALL found no association, it is unlikely
that the results obtained in this meta-analysis were due to
confounding eﬀect by maternal smoking.
The potential eﬀect of smoking in one time period on
outcomes associated with another time period, is another
confounding factor. Exposure to paternal ever smoking (in
lifetime or during any of the three time periods) was posi-
tively associated with childhood ALL, but it was weaker than
the eﬀect of exposure in speciﬁc time windows, indicating
a dilution of the eﬀect of paternal smoking in the time
window of interest by paternal ever smoking in lifetime.
However, it was diﬃcult to fully diﬀerentiate the eﬀects
of paternal smoking during diﬀerent time periods in the
current study. None of the studies looked at fathers who
smoked exclusively during speciﬁc exposure windows or
adjusted for paternal smoking in all other time periods. The
study by Chang et al. 2006 [23] showed that, compared to
children of lifetime nonsmoking fathers, the children of ever
smoking fathers who did not smoke during the 3-month
preconception period had an OR of 1.10 (95% CI: 0.63–
1.91) while the children of fathers who smoked during the
3-month preconception period had an increased OR of 1.35
(95%CI:0.86–2.10).Thus,includingpreconceptionpaternal
smokinginothertimewindowsofinterestmightbiastherisk
estimate away from null.
4.3. Potential Mechanisms of Action. Diﬀerent mechanisms
likely underlie ALLs arising from exposure to paternal
smoking pre- and postconception, and these are currently
poorly understood. Active paternal smoking has been shown
to deplete plasma and tissue antioxidant and increase
oxidative damage to sperm DNA [58]. It has also been
reported that mainstream tobacco smoke can cause paternal
germ-line DNA mutation among mature male mice and
that mutations accumulate in the spermatogonial stem cells
with extended exposures [59]. Two published reviews found
a suggestive causal relationship between paternal smoking
and all childhood cancers, including also brain cancer and
nerve system cancer, with signiﬁcant increased risk of 10%
to 20% [15, 60]. These lines of evidence provide biological
plausibility that preconception paternal smoking can cause
childhood leukemia. However, the elevated point estimate of
the association between paternal smoking in the one or three
months before conception was not statistically signiﬁcant.
This might be due to the low power of detection because
of the small number of studies (n = 5) analyzed in this
subgroup. Alternatively, this may indicate that the impact on
sperm and short lifespan may not be restricted to exposure
during this narrow preconception period. Cigarette smoking
has been shown to alter gene expression patterns in airway
epithelialcells,someirreversibly[61],andtoaltermicroRNA
expression proﬁling in bronchial cells, indicating possible
epigenetic eﬀects [62]. It is possible that sperm-producing
cells are negatively impacted by persistent changes in gene
or miRNA expression as a result of smoking at earlier times
than three months before conception. Further studies are
necessary to delineate the eﬀects on sperm in well-deﬁned
windows of exposure before conception.
The biological mechanism underlying ALL arising from
exposure during pregnancy or after birth could be mediated
through changes in the lymphocyte transcriptome and
subsequent eﬀectsontheimmune system, as hasbeenshown
for active smoking [63]. A paternal eﬀect in utero might14 Journal of Oncology
be expected to be weaker than a maternal eﬀect. However,
among the many studies which have investigated childhood
ALL and maternal smoking during pregnancy, only three
reported positive associations [27, 36, 39]. If carcinogenesis
is not mediated by maternal smoking during pregnancy, it
is less likely to be mediated by paternal smoking during
this time window. A possible explanation for the positive
association found in this meta-analysis is that most fathers
who smoked during the pregnancy likely also smoked before
thepregnancyorafter birth. Paternalsmoking statustends to
be constant during diﬀerent time periods [20]. This means
that a risk apparently associated with smoking during or
afterpregnancy may haveactuallyarisen frompreconception
exposure.
5.Conclusion/Impact
Evidence from the current meta-analysis strongly suggests
a positive association between paternal smoking and child-
hood ALL. Given the high prevalence of smoking among
males (35% in developed countries and 50% in developing
countries [8]), the association with ALL is of great relevance
to public health. Future molecular epidemiology studies
should be designed with better assessment of paternal smok-
ing during well-deﬁned time windows. Given that smoking
cessation is challenging, identifying the most relevant time
window and motivating fathers to quit at least during
that time window is one potential strategy to reduce the
burden of childhood leukemia. Studies should also facilitate
investigation of the underlying toxicological mechanisms,
such as genotoxic, transcriptomic, or epigenomic eﬀects on
sperm or cord blood.
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